| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
| A1 | 1 | 40 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| A2 | 2 | 62 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1N0M0 | I | Malignant |
| A3 | 3 | 63 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| A4 | 4 | 58 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1cN0M0 | IC | Malignant |
| A5 | 5 | 40 | F | Uterus | Endometrioid adenocarcinoma (sparse) | 1 | T1bN0M0 | IB | Malignant |
| A6 | 6 | 51 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| A7 | 7 | 57 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| A8 | 8 | 52 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1cN0M0 | IC | Malignant |
| A9 | 9 | 45 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant |
| A10 | 10 | 51 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| B1 | 11 | 68 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1cN0M0 | IC | Malignant |
| B2 | 12 | 62 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| B3 | 13 | 59 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| B4 | 14 | 51 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| B5 | 15 | 62 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1cN1M0 | IIIC | Malignant |
| B6 | 16 | 56 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| B7 | 17 | 62 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| B8 | 18 | 50 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| B9 | 19 | 60 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1cN0M0 | IC | Malignant |
| B10 | 20 | 51 | F | Uterus | Endometrioid adenocarcinoma | 1--2 | T1bN0M0 | IB | Malignant |
| C1 | 21 | 60 | F | Uterus | Endometrioid adenocarcinoma | 1--2 | T1bN0M0 | IB | Malignant |
| C2 | 22 | 55 | F | Uterus | Endometrioid adenocarcinoma | 1--2 | T1cN0M0 | IC | Malignant |
| C3 | 23 | 61 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1cN0M0 | IC | Malignant |
| C4 | 24 | 68 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1cN0M0 | IC | Malignant |
| C5 | 25 | 60 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| C6 | 26 | 50 | F | Uterus | Endometrioid adenocarcinoma (smooth muscle tissue) | * | T1bN0M0 | IB | Malignant |
| C7 | 27 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant |
| C8 | 28 | 67 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1cN0M0 | IC | Malignant |
| C9 | 29 | 72 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| C10 | 30 | 55 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
| D1 | 31 | 57 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant |
| D2 | 32 | 58 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant |
| D3 | 33 | 52 | F | Uterus | Endometrioid adenocarcinoma (smooth muscle tissue) | * | T1bN0M0 | IB | Malignant |
| D4 | 34 | 53 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1cN0M0 | IC | Malignant |
| D5 | 35 | 53 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1cN0M0 | IC | Malignant |
| D6 | 36 | 47 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1cN0M0 | IC | Malignant |
| D7 | 37 | 62 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1cN0M0 | IC | Malignant |
| D8 | 38 | 65 | F | Uterus | Endometrioid adenocarcinoma with squamous metaplasia | 3 | T1bN0M0 | IB | Malignant |
| D9 | 39 | 54 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1cN0M0 | IC | Malignant |
| D10 | 40 | 56 | F | Uterus | Endometrioid adenocarcinoma (chronic inflammion of smooth muscle) | * | T2aN0M0 | IIA | Malignant |
| E1 | 41 | 48 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3N0M0 | III | Malignant |
| E2 | 42 | 49 | M | Uterus | Serous adenocarcinoma | 2--3 | T1bN0M0 | IB | Malignant |
| E3 | 43 | 60 | F | Uterus | Serous adenocarcinoma | 1 | T3aN0M0 | IIIA | Malignant |
| E4 | 44 | 72 | F | Uterus | Clear cell adenocarcinoma | 2 | T1cN0M0 | IC | Malignant |
| E5 | 45 | 50 | F | Uterus | Clear cell adenocarcinoma | 2 | T2bN0M0 | IIB | Malignant |
| E6 | 46 | 21 | F | Uterus | Normal endometrium tissue | * | * | * | Normal |
| E7 | 47 | 41 | F | Uterus | Normal endometrium tissue | * | * | * | Normal |
| E8 | 48 | 18 | F | Uterus | Normal endometrium tissue | * | * | * | Normal |
| E9 | 49 | 21 | F | Uterus | Normal endometrium tissue | * | * | * | Normal |
| E10 | 50 | 21 | F | Uterus | Normal endometrium tissue (smooth muscle and blood vessel) | * | * | * | Normal |
| F1 | 51 | | | | | | | | |
